Efficacy and safety of combined treatment with pembrolizumab in patients with locally advanced or metastatic esophageal squamous cell carcinoma in the real world

BACKGROUND: Treatments for patients with advanced esophageal cancer are still limited. Pembrolizumab has demonstrated antitumor activity in patients with advanced esophageal cancer in previous studies. Few studies have assessed safety and efficacy in routine clinical practice. We investigated the re...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Pei, Hou, Xiaobin, Cai, Boning, Yu, Wei, Chen, Jing, Huang, Xiang, Li, Ye, Zeng, Mingyue, Ren, Zhipeng, Gabriel, Emmanuel, Qu, Baolin, Liu, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279766/
https://www.ncbi.nlm.nih.gov/pubmed/35845479
http://dx.doi.org/10.21037/atm-22-2779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279766/
https://www.ncbi.nlm.nih.gov/pubmed/35845479
http://dx.doi.org/10.21037/atm-22-2779

Ejemplares similares